In a large single-center retrospective study including Chinese patients with PHPT (259), parathyroid carcinoma patients presented with significantly higher serum calcium and PTH levels and bone turnover markers, and lower BMD at total hip and femoral neck, compared to patients with benign adenoma/hyperplasia. The gene discussed is PTH; the disease is parathyroid gland carcinoma.